NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

Ultimately, ‘everything takes longer’ with NWBO and watching this debate has been amusing.

Those of us shareholders who are realistic can just continue to buy more NWBO in good confidence and average down.

We know that even if the SP gets no help from Bethesda and only say doubles or triples on MHRA approval, that puts a lot of us permanently in the green and creates a big profit on those new shares we bought while on the clock for approval. With the way things might drag out, by the time the price hits a very high point where we are willing to sell, the new shares might be taxable as long term gains too.

Not everyone has learned the hard way to stop expecting anything to be soon, let alone have the impact on the SP it should.

The discovery that there are magically newly discovered ‘sub-steps’ to the MHRA process including the potential for ‘off clock’ time is doubtless frustrating to those of us who insist on believing that at some point all that waiting up front should finally buy them a shorter wait on the back end. In a just world it would but if we lived in a just world there would be no GBM and NWBO would not need to exist.

Their frustration can’t be taken out on NWBO or MHRA (not good for their version of the investing thesis) so they take it out on those who point out that with NWBO there are no short cuts.

We will make good money as shareholders in NWBO in 2024 and large numbers of patients will start benefitting in 2025. It will not happen ‘soon’ though.

I remain a buyer as I was in 2023. Others can do what they like, as always. There really isn’t much to say until real news.